This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Swanson, D. P. Articles by Jurgens, R. W. Search for Related Content Social Bookmarking                         What's this?

Radiopaque Contrast Media: The Role of the Pharmacist

School of Pharmacy, 1103 Salk Hall, University of Pittsburgh, Pittsburgh, PA 15261.

Raymond W. Jurgens

School of Pharmacy, 1103 Salk Hall, University of Pittsburgh, Pittsburgh, PA 15261.

Radiopaque contrast media (ROCM) are diagnostic drugs used for the enhancement of radiographic (x-ray) examinations. Although these agents have been used extensively for several years, pharmacist involvement with this category of drugs, to date, has been minimal. This article outlines several aspects of contrast media use in which pharmacists can or should become actively involved. Included in this discussion are possible roles of the pharmacist in decisions regarding respective product efficacy and use; adverse reaction prevention, reporting, monitoring, and treatment; and the evaluation of potential contrast media-drug or contrast media-laboratory test interactions. Pharmacist involvement associated with the use of traditional drugs in the performance of radiographic examinations and with technological advancements in radiology are also addressed. The overall magnitude of drug activity encountered in a radiology department suggests a needed and important role for pharmacists interested in this area.

Journal of Pharmacy Practice, Vol. 2, No. 3, 162-170 (1989)
DOI: 10.1177/089719008900200305


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?